Stanford M. Shoor, MD - Rheumatology

Dr. Stanford Shoor reviews medical content for Healthwise, a nonprofit organization with a mission to help people make better health decisions. Dr. Shoor, an internist specializing in rheumatology, has been on the Clinical Faculty of Stanford University since 1986 and currently holds an appointment as an Adjunct Clinical Professor of Medicine and Rheumatology.

Dr. Shoor has served as principal investigator or co-investigator for a number of research projects sponsored by Kaiser Health Plan and the Stanford Arthritis Center. He serves on the medical review boards for the Journal of General Internal Medicine, Permanente Journal, ACP Journal, and the Evidence Based Medicine section of the British Medical Journal (BMJ).

Board Certifications

American Board of Internal Medicine—1982
American Board of Internal Medicine, Subspecialty: Rheumatology—1984

Healthwise Knowledgebase Topics Reviewed

Gout
Juvenile Rheumatoid Arthritis
Medical Tests: Antinuclear Antibodies, Erythrocyte Sedimentation Rate, Rheumatoid Factor
Osteoarthritis
Raynaud's Syndrome
Rheumatoid Arthritis
Sjögren's Syndrome
Systemic Lupus Erythematosus

Education

M.D.: Stanford University School of Medicine, 1979
Internship, University of Washington, 1978–1980
Residency, University of Washington, 1980–1982
Robert Wood Johnson Clinical Scholar, Stanford University School of Medicine, 1982–1984
Fellowship in Immunology, Stanford University School of Medicine, 1982–1984

Academic Appointments

Adjunct Clinical Professor of Medicine and Rheumatology, Stanford University, 1986–present

Hospital Affiliations

Staff Director, Mid-Peninsula Health Service, 1973–1975
Internist, Rheumatology, Kaiser Foundation Hospital, Santa Clara, California, 1984–present
Chief of Professional Education, Kaiser Foundation Hospital, Santa Clara, 1988–present

Professional Affiliations

American College of Physicians

American College of Rheumatology

Selected Publications

  1. O'Leary A, Shoor SM, Lorig K, Holman HR (1988). A cognitive-behavioral treatment for rheumatoid arthritis. Health Psychology 7(6): 527–544.
  2. Lorig K, Chastain RL, Ung E, Shoor S, Holman HR (1989). Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis and Rheumatology 32(1): 37–44.
  3. Graham, DJ, Campen D, Hui R, Spence M, Cheetham C, Shoor S, Ray W (2005). Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective nonsteroidal anti-inflammatory drugs: Nested case control study. Lancet, 365(9468): 475–481.
  4. Herrinton L, Liu L, Shoor S, Mines D (2008). Risk of lymphoproliferative cancer among patients with severe rheumatoid arthritis, 1996-2002. Annals of the Rheumatic Diseases, 67(4): 574–575.

Financial Disclosure

This reviewer reported no financial conflicts.

related physicians

related services

Bon Secours International| Sisters of Bon Secours USA| Bon Secours Health System

This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Privacy Policy. How this information was developed to help you make better health decisions.

© 1995-2010 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.